Timothy de Gavre

Timothy de Gavre has a diverse work experience spanning multiple industries and roles. Timothy has worked at Sandoz since 2010, where they held various positions such as VP & Chief Commercial Officer (CCO) in the US, VP Key Accounts & Sales US, GM & Country Head in the UK, Head Specialty in the UK, Global Brand Director, and Head of Global Strategic Planning for Biopharmaceuticals & Oncology Injectables. Prior to their time at Sandoz, Timothy worked at the British Generic Manufacturers Association (BGMA) as Chair from 2018 to 2020 and as the Founding Chair of the British Biosimilars Association (BBA) from 2016 to 2017. Timothy also has experience at McKinsey & Company as an Engagement Manager and Associate, Frazier Healthcare Partners as a Senior Financial Analyst, and ISO Healthcare Consulting as a Consultant.

Timothy de Gavre completed their Bachelor's degree in European History from Princeton University between 1992 and 1996. Timothy later pursued a Master of Business Administration (MBA) in Healthcare Management from The Wharton School from 2003 to 2005.